Wearable hormone trackers are coming. What Lume actually measures.

The pitch is seductive. A wristband that shows you your stress hormone, cortisol, rising and falling across the day, the way a glucose monitor shows blood sugar. Lume Health, a San Francisco startup, has a waitlist of more than 5,200 people waiting for exactly that. It is worth looking closely at what the company is actually promising, because the gap between the headline and the hardware is the whole story.

What Lume is, and is not, today

Start with the plainest fact. You cannot buy Lume. The company has raised about 2.5 million dollars and, on its own site, plans a beta in 2027. What exists now is a waitlist and a promise, not a product on a wrist.

The founders are credible. Vicki Powell is a former Apple sensor engineer and Dr. Jonathan Moustakis is a physician, and the problem they have picked, giving people a live read on the hormone behind stress, is a genuinely useful one. None of that is in doubt. What is worth slowing down on is the specific claim being made about how the first device works, because that is where marketing and engineering pull apart.

Estimating a hormone is not the same as reading it

Most coverage calls Lume a sweat-sensing wristband that tracks hourly cortisol. Read the company's own How It Works page and a more modest picture appears. Lume says its band starts from the signals your wearable already records, heart rate, movement, temperature and sleep, adds a sweat measurement, and combines these with a few calibrating saliva samples to estimate your cortisol rhythm.

Estimate is the operative word. The near-term Lume does not pull cortisol directly out of your sweat and report a number. It infers a daily curve from proxies, checked against occasional saliva tests. To the company's credit, it is open about this, and describes a sensor that reads cortisol directly and continuously from sweat as a next step it is still building. That is an honest distinction, and it changes what the first product can honestly claim to be.

Why this is hard in the first place

The reason nobody has simply shipped a cortisol version of the glucose monitor is chemistry, not laziness. Free cortisol circulates at concentrations more than a million times lower than glucose, according to Adaptyx Biosciences, another company chasing continuous cortisol sensing. That rules out the cheap enzyme reaction that made continuous glucose monitors possible, and forces far more delicate and expensive sensor designs.

It shows in the field's most advanced results. The first continuous cortisol data in humans, presented by Adaptyx in June 2026, reads from the fluid just under the skin rather than sweat, and is a research finding, not a product you can order. Sweat, the medium Lume is aiming at, is easier to reach and, as IEEE Spectrum described it, a less faithful mirror of the blood. That trade buys convenience at the cost of accuracy, which is exactly the compromise a stress dashboard cannot afford to hide.

What actually works today

If you want hormone data at home right now, the validated tools are not wearables. For reproductive hormones, quantitative urine monitors from Mira, Inito and Oova measure markers such as luteinising hormone and estrogen and progesterone metabolites, with peer-reviewed validation behind Mira and Inito. They are not continuous and not glamorous, but they have published data standing behind them. And for a single, absolute hormone value at a point in time, a clinician-ordered blood panel remains the reference standard that everything else is measured against.

That is the fair frame for Lume. Its promise, a time-resolved rhythm that a one-off blood draw simply cannot show, is real and interesting. But today that rhythm is an estimate, produced by a device you cannot yet buy, and marketed as wellness rather than medicine.

Our take

Lume is a first mover in a category that barely exists yet, and it deserves some credit for being clearer on its own site than many of the headlines written about it. The cortisol wristband is probably coming, but the version arriving first estimates rather than measures, and it is a wellness gadget, not a diagnostic. If your stress genuinely feels unmanageable, the next step is a conversation with a doctor and possibly a proper cortisol test, not a waitlist. Watch this space in 2027, and when the device ships, judge it by whether it publishes accuracy data against blood, not by the size of its waitlist.

This is general information, not medical advice. If you are worried about chronic stress, persistent fatigue or a possible hormone disorder, speak to a clinician.